Skip to main content
Jointown Pharmaceutical Group Co., Ltd logo

Jointown Pharmaceutical Group Co., Ltd — Investor Relations & Filings

Ticker · 600998 ISIN · CNE100000W45 LEI · 300300875YINDA6F8T86 Shanghai Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 2,736 across all filing types
Latest filing 2026-05-21 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 600998

About Jointown Pharmaceutical Group Co., Ltd

https://www.jointown.com/

Jointown Pharmaceutical Group Co., Ltd. specializes in the distribution and supply chain management of pharmaceutical products and medical devices. The company operates an extensive logistics network that facilitates the wholesale and retail of Western medicines, traditional Chinese medicines, and medical instruments. Core business activities include pharmaceutical warehousing, cold chain logistics, and digital supply chain services designed to optimize the flow of healthcare products. Jointown serves a diverse client base, including hospitals, community health centers, and retail pharmacies. By leveraging advanced information technology and automated logistics systems, the company provides integrated solutions for pharmaceutical procurement and distribution, focusing on efficiency and safety in the healthcare supply chain.

Recent filings

Filing Released Lang Actions
九州通2025年度股东会法律意见书
Regulatory Filings Classification · 78% confidence The document is a legal opinion letter (‘法律意见书’) prepared by a law firm regarding the procedures, attendance, voting process and results of the company’s 2025 Annual General Meeting. It is not the AGM presentation material itself, nor is it a financial report (10-K/IR), proxy statement, or other specified category. It does not contain actual financial statements, nor is it an announcement of dividend, share issue, or corporate action. It is best classified under the fallback category for miscellaneous regulatory/legal filings (RNS).
2026-05-21 Chinese
九州通关于为子公司提供担保的进展公告
Capital/Financing Update Classification · 83% confidence The document is a full announcement by the listed company detailing amounts, counterparties, board approvals, and tables of guarantees provided to its subsidiaries to support their bank financing. It is not an earnings report, director change, or regulatory notice of report publication, but rather a financing‐related update on guarantees (a capital/financing activity). Therefore it best fits the “Capital/Financing Update” category (CAP).
2026-05-19 Chinese
九州通关于股东会开设网络投票提示服务的公告
Proxy Solicitation & Information Statement Classification · 75% confidence The document is an announcement by the Board regarding an upcoming 2025 Annual General Meeting and outlines a network-voting reminder service to inform and prompt shareholders to attend and vote. It contains no financial data or voting results but is clearly an information notice sent to shareholders to facilitate and request their votes at the meeting. This aligns with the “Proxy Solicitation & Information Statement (PSI)” category.
2026-05-14 Chinese
九州通关于召开2025年年度股东会的提示性公告
Proxy Solicitation & Information Statement Classification · 92% confidence The document is a notice of the company’s 2025 Annual General Meeting, detailing meeting date/time, agenda items (proposals), voting methods, eligibility, and including a proxy authorization form. It is materials sent to shareholders to inform about the meeting and solicit votes, matching the definition of a Proxy Solicitation & Information Statement (PSI).
2026-05-14 Chinese
中信证券股份有限公司关于九州通2024年度向特定对象发行优先股持续督导保荐总结报告书
Regulatory Filings Classification · 85% confidence The document is a “持续督导保荐总结报告书” prepared by the sponsor (中信证券) summarizing its continuous supervision work on a specific securities issuance (preferred shares) by 九州通医药集团 in 2024. It is not a financial report itself (like an interim/annual report), nor an earnings release, but a regulatory compliance filing by the sponsor to the stock exchange/regulator summarizing its duties under listing rules. It does not fit focused categories like a share issue announcement (SHA) or capital update press release (CAP), but is best classified under general “Regulatory Filings” (RNS) as a compliance document.
2026-05-12 Chinese
中信证券股份有限公司关于九州通2025年持续督导工作现场检查结果及提请公司注意事项
Regulatory Filings
2026-05-06 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.